The primary objective of this study is to establish circulating tumor cell (CTC) derived xenografts and assess the activity of novel DNA repair inhibitors as a function of DNA repair mutations detected in CTC samples (personalize DNA repair therapy).
The primary objective of this study is to establish circulating tumor cell (CTC) derived xenografts and assess the activity of novel DNA repair inhibitors as a function of DNA repair mutations detected in CTC samples (personalize DNA repair therapy).
Circulating Tumor Cells (CTC) in Lung Cancer
-
Indiana University Health Hospital, Indianapolis, Indiana, United States, 46202
Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States, 46202
Roudebush VA Medical Center, Indianapolis, Indiana, United States, 46202
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Shadia Jalal,
Shadia Jalal, MBBS, PRINCIPAL_INVESTIGATOR, Indiana University School of Medicine, Indiana University Simon Cancer Center
2025-10-31